John E Dick

43PUBLICATIONS

276CO-AUTHORS

Haematological tumoursHaematologyPredictive and prognostic markersMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (43)

Sort by Publication Date:

|Jul 01, 2026

FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.

|May 27, 2026

Human haematopoietic stem cells remember inflammatory stress.

|May 05, 2026

ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.

|May 04, 2026

Transposable elements shape stemness in normal and leukemic hematopoiesis.

|Nov 24, 2025

A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard Therapies.

Stephen E Kurtz, Christopher A Eide, Andy Kaempf

|Nov 14, 2025

Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation.

Tianyi Ling, Cristiana O'Brien, Jonathan R St-Germain

Pageof 8

Frequent Collaborators

10 joint publications

Charles G Mullighan

Mark Minden

Elvin Wagenblast

Kerstin B Kaufmann

Michelle Chan-Seng-Yue

Sagi Abelson

Andy G X Zeng

Jean C Y Wang

Stephanie Z Xie

Gary D Bader

Frequent Collaborators

10 joint publications

Charles G Mullighan

9 joint publications

Mark Minden

7 joint publications

Elvin Wagenblast

7 joint publications

Kerstin B Kaufmann